Cell-free fetal DNA and spontaneous preterm birth

scientific article published on 21 December 2017

Cell-free fetal DNA and spontaneous preterm birth is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1530/REP-17-0619
P932PMC publication ID5812054
P698PubMed publication ID29269517

P2093author name stringJane E Norman
Sarah J Stock
Donald J Davidson
Sara R van Boeckel
P2860cites workSTING: infection, inflammation and cancerQ26776009
Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer TherapeuticsQ26784480
Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and diseaseQ26991553
Sterile inflammation and pregnancy complications: a reviewQ28071315
Epidemiology and causes of preterm birthQ29615799
Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issuesQ33838434
Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasmaQ34336915
Rapid clearance of fetal DNA from maternal plasmaQ34388637
Cell-free fetal DNA and cell-free total DNA levels in spontaneous abortion with fetal chromosomal aneuploidyQ34607066
Cell-free fetal nucleic acids in amniotic fluidQ34768792
Cell-free fetal DNA and pregnancy-related complications (review)Q35110814
Prevention of CpG-induced pregnancy disruption by adoptive transfer of in vitro-induced regulatory T cells.Q35143080
Placental extracellular vesicles and feto-maternal communication.Q35164277
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathologyQ35543094
Ultrasound-guided intrauterine injection of lipopolysaccharide as a novel model of preterm birth in the mouseQ35568267
Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell LineQ35680341
Circulating fetal DNA: its origin and diagnostic potential-a reviewQ35699978
Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation?Q36182206
Therapeutic potential of Toll-like receptor 9 activationQ36501229
TLR9 in health and diseaseQ36526346
Prognostic utility and characterization of cell-free DNA in patients with severe sepsisQ36634005
Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistanceQ36764022
Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsiaQ37061065
Differential effects of the CpG-Toll-like receptor 9 axis on pregnancy outcome in nonobese diabetic mice and wild-type controlsQ37130691
Inflammatory processes in preterm and term parturition.Q37190093
TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomesQ37447389
Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.Q37778114
Cell-free nucleic acids in (maternal) blood: any relevance to (reproductive) immunologists?Q38210816
Maternal plasma fetal DNA as a marker for preterm labour.Q50851221
Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse.Q51028864
Which intervention reduces the risk of preterm birth in women with risk factors?Q51145180
A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.Q51796196
Excessive TLR9 signaling contributes to the pathogenesis of spontaneous abortion through impairment of Treg cell survival by activation of Caspase 8/3.Q52665404
A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage.Q53334658
High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery.Q54648888
Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation.Q54688617
Presence of fetal DNA in maternal plasma and serumQ57075132
Maternal Plasma Cell-Free Fetal and Maternal DNA at 11-13 Weeks' Gestation: Relation to Fetal and Maternal Characteristics and Pregnancy OutcomesQ61847818
High levels of fetal DNA are associated with increased risk of spontaneous preterm deliveryQ61848064
Toll-erating self DNAQ81632664
The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsiaQ82204583
Free fetal DNA levels in patients at risk of preterm labourQ84941296
Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm deliveryQ85633128
Cell-free fetal DNA and adverse outcome in low risk pregnanciesQ87393141
Cell-free fetal DNA--a trigger for parturitionQ88151873
Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages.Q38301981
CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.Q38316638
Term labor is associated with a core inflammatory response in human fetal membranes, myometrium, and cervixQ38511297
Cell-Free Fetal DNA, Telomeres, and the Spontaneous Onset of ParturitionQ38541725
Noninvasive nucleic acid-based approaches to monitor placental health and predict pregnancy-related complications.Q38597295
Inflammation and preterm birthQ38625684
Cell-free DNA fetal fraction and preterm birthQ38908291
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implicationsQ38911854
Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-AnalysisQ39006810
Human β-defensin 3 increases the TLR9-dependent response to bacterial DNAQ39012844
Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulationQ39032748
Cytosolic nucleic acid sensors and innate immune regulationQ39195781
TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsiaQ39356539
Cell-free DNA, inflammation, and the initiation of spontaneous term laborQ40201763
Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomesQ40544172
Exposure to stimulatory CpG oligonucleotides during gestation induces maternal hypertension and excess vasoconstriction in pregnant ratsQ40792782
Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicismQ43073795
The history of Toll-like receptors - redefining innate immunity.Q46240771
Smoking in pregnancy is associated with increased total maternal serum cell-free DNA levelsQ46764579
Antiphospholipid antibodies increase the levels of mitochondrial DNA in placental extracellular vesicles: Alarmin-g for preeclampsiaQ47105114
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectpreterm birthQ625506
embryonic structureQ30062554
cell-free nucleic acidQ66981054
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)R137-R145
P577publication date2017-12-21
2018-02-01
P1433published inReproductionQ7314293
P1476titleCell-free fetal DNA and spontaneous preterm birth
P478volume155

Reverse relations

cites work (P2860)
Q89660275Cell-Free Fetal DNA Increases Prior to Labor at Term and in a Subset of Preterm Births
Q92110121Effect of cell-free fetal DNA on spontaneous preterm labor
Q92756215Exosomes-Associated DNA-New Marker in Pregnancy Complications?
Q91591027Inflammation-mediated generation and inflammatory potential of human placental cell-free fetal DNA
Q89533651Multiomic immune clockworks of pregnancy
Q90248296Role of the NLRP3 Inflammasome in Preeclampsia

Search more.